Parallel Advisors’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9K | Sell |
785
-314
| -29% | -$10.4K | ﹤0.01% | 2057 |
|
|
2025
Q1 | $44.2K | Buy |
1,099
+916
| +501% | +$36.8K | ﹤0.01% | 1697 |
|
|
2024
Q4 | $8.61K | Sell |
183
-229
| -56% | -$10.8K | ﹤0.01% | 2433 |
|
|
2024
Q3 | $21.8K | Sell |
412
-67
| -14% | -$3.54K | ﹤0.01% | 2043 |
|
|
2024
Q2 | $26K | Buy |
479
+144
| +43% | +$7.8K | ﹤0.01% | 1828 |
|
|
2024
Q1 | $23.5K | Buy |
335
+3
| +0.9% | +$210 | ﹤0.01% | 1895 |
|
|
2023
Q4 | $27.7K | Buy |
332
+43
| +15% | +$3.59K | ﹤0.01% | 1745 |
|
|
2023
Q3 | $8.51K | Buy |
289
+276
| +2,123% | +$8.13K | ﹤0.01% | 2281 |
|
|
2023
Q2 | $424 | Buy |
+13
| New | +$424 | ﹤0.01% | 3127 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$458 | – | 3423 |
|
|
2022
Q4 | $458 | Buy |
+10
| New | +$458 | ﹤0.01% | 3046 |
|
|
2022
Q2 | – | Sell |
-7
| Closed | – | – | 3041 |
|
|
2022
Q1 | $0 | Buy |
+7
| New | – | ﹤0.01% | 3018 |
|
|
2020
Q2 | – | Sell |
-48
| Closed | – | – | 2480 |
|
|
2020
Q1 | $0 | Buy |
+48
| New | – | ﹤0.01% | 2422 |
|
|
2017
Q4 | – | Sell |
-1,200
| Closed | -$14K | – | 2087 |
|
|
2017
Q3 | $14K | Sell |
1,200
-500
| -29% | -$5.83K | ﹤0.01% | 1139 |
|
|
2017
Q2 | $24K | Hold |
1,700
| – | – | ﹤0.01% | 937 |
|
|
2017
Q1 | $27K | Sell |
1,700
-1,000
| -37% | -$15.9K | 0.01% | 844 |
|
|
2016
Q4 | $33K | Buy |
+2,700
| New | +$33K | 0.01% | 694 |
|